Table 1 Clinical characteristics of MS patients
From: Clinical predictors to cognitive impairment in multiple sclerosis patients
| Patients | ||
|---|---|---|
|
Frequency (N = 45) | Percentage | |
| Type of MS | ||
| RRMS | 30 | 66.7 |
| SPMS | 15 | 33.3 |
| Type of first attack | ||
| Motor | 22 | 48.9 |
| Cerebellar | 13 | 28.9 |
| Visual | 7 | 15.6 |
| Sensory | 3 | 6.7 |
| Attack/year | ||
| One | 9 | 20.0 |
| Two | 23 | 51.1 |
| Three | 13 | 28.9 |
| Treatment | ||
| Interferon B1b | 13 | 28.9 |
| Monthly cyclophosphamide + methylprednisolone | 11 | 24.4 |
| Fingolimod | 8 | 17.8 |
| Interferon Beta 1a | 7 | 15.6 |
| Azathioprine | 5 | 11.1 |
| Cyclophosphamide | 1 | 2.2 |